Abstract:OBJECTIVE:To develop pulsatile release pellets using tanshinone II as model drug and evaluate their properties in vitro.METHODS:The tanshinone II pusatile release pellets with rupturable coatings were prepared by fluid bed. Hydroxy propyl methyl cellulose (HPMC), low-substituted hydroxy propyl cellulose (L-HPC)/HPMC, and HPMC/Sureleae were used as swelling agents respectively, and aqueous ethylcellulose dispersion Surelease as the material of controlled layer. Dissolution experiments were employed to evaluate the effects of different swelling agents and weight gain of each coating layer. Cross-sections of pellets with different swelling agents were observed by scanning electron microscope (SEM). The release profiles of tanshinone II from the coated pellets were fitted into various mathematic models.RESULTS:Pellets with HPMC or L-HPC/HPMC as swelling agents could not present a significant release lag time. However, the pellets with the mixture of HPMC and Surelease as swelling agents could. As the ratio of Surelease increased in swelling layer, the lag time could be extended. As to the controlled layer, the thicker the controlled layer, the longer the lag time could be. When the controlled layer was coated by 30%-40% weight gains, 3-5 h lag time was realized. The fitted model suggested that first order equation could explain the drug release from tanshinone II pulsatile release pellets.CONCLUSION:Using HPMC/Surelease mixture as swelling agents, and Surelease as the material of controlled layer, tanshinone II pulsatile release pellets with 3-5 h lag time were successfully prepared.

Preparation and in Vitro Evaluation of Zaleplon Pulsatile Release Pellets

Preparation of Double Pulse Control Release Pellets of Zolpidem Tartrate

Study on pramipexole dihydrochloride sustained-release tablets

Preparation and in Vitro Evaluation of Diclofenac Potassium Delayed-Sustained Release Pellets

[Studies on Preparation of Isosorbide-5-mononitrate Pulsatile Controlled-Release Pellets and Various Influence Factors].

Preparation of Amoxicillin and Clavulanate Potassium Pulsatile Capsules

[Preparation and in Vitro Evaluation of Tanshinone IIA Pulsatile Release Pellets].

Preparation of Cefalexin Sustained-release Pellets and Investigation on Its Drug Release in Vitro

Studies on Preparation and in vitro Release of Levodropropizine Modified-release Capsules

Preparation and In-Vitro Release of Metformin Hydrochloride Sustained-Release Pellets

Design and evaluation of pH-independent pulsatile release pellets containing isosorbide-5-mononitrate.

Preparation, Characterization and In Vitro / In Vivo Evaluation of Oral Time-Controlled Release Etodolac Pellets

Preparation of Sinomenine Hydrochloride Enteric-coated and Sustained-release Pellets

Optimization of Preparation Process and Pharmacokinetics of APAP Double-Release Pellet Capsules

Preparation and in Vitro Release Study of Sustained-release Coated Pellets Containing Clarithromycin

[Preparation of Sustained-Release Capsules of Zaltoprofen].

Preparation of Oxaceprol Coated Controlled-Release Tablet and Quality Evaluation

Preparation of Zhitong Sustained-Release Tablet and Its Release Property in Vitro

Preparation of Sustained-Release and Enteric Coated Pellets of Pantoprazole

Preparation and Quality Evaluation of Ibuprofen Sustained Release Pellet Capsules Based on Solid Dispersion Technology

Preparation of Salbutamol Sulphate Pulsatile Release Tablets